Compared to patients with mild/moderate COVID-19, our CCC analysis suggested that epidermal growth factor receptor (EGFR) signaling from ciliated cells to other cell types was lost in patients with severe COVID-19 (Figures 4B, C). The gene discussed is EGFR; the disease is COVID-19.